1 year return (CAGR)
285.71%
Prelude Therapeutics Inc Exchange (NASDAQ, USD)
PRLD
4.59
-0.08 (-1.71%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
8.33%
5 year return (CAGR)
-34.70%
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
298.70M
Price/Sales
13.32
Ent value
328.00M
Price/Book
2.23
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-22.29%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 4.72 |
| Daily high | 4.75 |
| Daily low | 4.56 |
| Daily Volume | 520K |
| All-time high | 91.68 |
| 1y analyst estimate | 8.00 |
| Beta | 0.94 |
| EPS (TTM) | -0.61 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 18 Mar 2026 |
Downside potential
Loading...
Downside potential data
| PRLD | S&P500 | |
| Current price drop from All-time high | -94.99% | -1.75% |
| Highest price drop | -99.33% | -56.47% |
| Date of highest drop | 8 Apr 2025 | 9 Mar 2009 |
| Avg drop from high | -85.56% | -10.69% |
| Avg time to new high | 62 days | 12 days |
| Max time to new high | 1403 days | 1805 days |
News
